seed
Stage
1
Investors
About
Eleven Biotherapeutics, Inc develops novel biotherapeutic drugs targeting ophthalmic and other diseases.
Explore Eleven Biotherapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.